| Host: |
Rabbit |
| Applications: |
IHC |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-NOV (32-357) is suitable for use in Immunohistochemistry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
IHC-P 1:50-1:100 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
CCN3 |
| Gene ID: |
4856 |
| Uniprot ID: |
CCN3_HUMAN |
| Immunogen Region: |
32-357 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 32-357 of human NOV (NP_002505.1). |
| Immunogen Sequence: |
TQRCPPQCPGRCPATPPTCA PGVRAVLDGCSCCLVCARQR GESCSDLEPCDESSGLYCDR SADPSNQTGICTAVEGDNCV FDGVIYRSGEKFQPSCKFQC TCRDGQIGCVPRCQLDVLLP EPNCPAPRKVEVPGECCEKW ICGPDEEDSLGGLTLAAYRP EATLGVEVSDSSVNCIEQTT EWTACSKSCGMGFSTRVTNR NRQCEMLKQTRLCMVRPCEQ EPEQPTDKKGKKCLRTKKS |
| Tissue Specificity | Expressed in endiothelial cells (at protein level). Expressed in bone marrow, thymic cells and nephroblastoma. Increased expression in Wilms tumor of the stromal type. |
| Post Translational Modifications | May be palmitoylated on Cys-244, which is important for extracellular secretion. |
| Function | Immediate-early protein playing a role in various cellular processes including proliferation, adhesion, migration, differentiation and survival. Acts by binding to integrins or membrane receptors such as NOTCH1. Essential regulator of hematopoietic stem and progenitor cell function. Inhibits myogenic differentiation through the activation of Notch-signaling pathway. Inhibits vascular smooth muscle cells proliferation by increasing expression of cell-cycle regulators such as CDKN2B or CDKN1A independently of TGFB1 signaling. Ligand of integrins ITGAV:ITGB3 and ITGA5:ITGB1, acts directly upon endothelial cells to stimulate pro-angiogenic activities and induces angiogenesis. In endothelial cells, supports cell adhesion, induces directed cell migration (chemotaxis) and promotes cell survival. Also plays a role in cutaneous wound healing acting as integrin receptor ligand. Supports skin fibroblast adhesion through ITGA5:ITGB1 and ITGA6:ITGB1 and induces fibroblast chemotaxis through ITGAV:ITGB5. Seems to enhance bFGF-induced DNA synthesis in fibroblasts. Involved in bone regeneration as a negative regulator. Enhances the articular chondrocytic phenotype, whereas it repressed the one representing endochondral ossification. Impairs pancreatic beta-cell function, inhibits beta-cell proliferation and insulin secretion. Plays a role as negative regulator of endothelial pro-inflammatory activation reducing monocyte adhesion, its anti-inflammatory effects occur secondary to the inhibition of NF-kappaB signaling pathway. Contributes to the control and coordination of inflammatory processes in atherosclerosis. Attenuates inflammatory pain through regulation of IL1B- and TNF-induced MMP9, MMP2 and CCL2 expression. Inhibits MMP9 expression through ITGB1 engagement. |
| Protein Name | Ccn Family Member 3Cellular Communication Network Factor 3Insulin-Like Growth Factor-Binding Protein 9Ibp-9Igf-Binding Protein 9Igfbp-9Nephro Blastoma-Overexpressed Gene Protein HomologProtein Nov HomologNovh |
| Cellular Localisation | SecretedCytoplasmCell JunctionGap JunctionLocalizes At The Gap Junction In Presence Of Gja1 |
| Alternative Antibody Names | Anti-Ccn Family Member 3 antibodyAnti-Cellular Communication Network Factor 3 antibodyAnti-Insulin-Like Growth Factor-Binding Protein 9 antibodyAnti-Ibp-9 antibodyAnti-Igf-Binding Protein 9 antibodyAnti-Igfbp-9 antibodyAnti-Nephro Blastoma-Overexpressed Gene Protein Homolog antibodyAnti-Protein Nov Homolog antibodyAnti-Novh antibodyAnti-CCN3 antibodyAnti-IGFBP9 antibodyAnti-NOV antibodyAnti-NOVH antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
